Diligent Investors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,426
Closed -$203K 370
2024
Q3
$203K Buy
+2,426
New +$185K 0.05% 336
2024
Q1
Sell
-2,479
Closed -$201K 334
2023
Q4
$201K Buy
+2,479
New +$193K 0.06% 299
2023
Q1
Sell
-2,340
Closed -$201K 288
2022
Q4
$201K Buy
+2,340
New +$185K 0.07% 263
2020
Q4
Sell
-3,356
Closed -$212K 221
2020
Q3
$212K Buy
3,356
+149
+5% +$10.3K 0.1% 175
2020
Q2
$247K Buy
3,207
+30
+0.9% +$2.3K 0.12% 150
2020
Q1
$238K Sell
3,177
-398
-11% -$27.5K 0.14% 133
2019
Q4
$232K Buy
3,575
+104
+3% +$6.77K 0.1% 178
2019
Q3
$220K Buy
3,471
+226
+7% +$14.8K 0.11% 190
2019
Q2
$219K Sell
3,245
-103
-3% -$6.78K 0.11% 188
2019
Q1
$218K Buy
+3,348
New +$223K 0.12% 177
2018
Q4
Sell
-2,756
Closed -$213K 195
2018
Q3
$213K Sell
2,756
-335
-11% -$25.3K 0.12% 176
2018
Q2
$219K Sell
3,091
-110
-3% -$7.77K 0.13% 163
2018
Q1
$241K Buy
3,201
+75
+2% +$5.96K 0.15% 159
2017
Q4
$224K Sell
3,126
-60
-2% -$4.56K 0.14% 165
2017
Q3
$258K Sell
3,186
-200
-6% -$15.3K 0.19% 137
2017
Q2
$240K Buy
3,386
+399
+13% +$26.6K 0.17% 143
2017
Q1
$203K Buy
2,987
+1
+0% +$70 0.16% 148
2016
Q4
$214K Buy
2,986
+365
+14% +$27.1K 0.17% 146
2016
Q3
$208K Sell
2,621
-16
-0.6% -$1.3K 0.17% 149
2016
Q2
$220K Buy
+2,637
New +$234K 0.21% 131

Other funds holding GILD

Diligent Investors's GILD Position: Q4 2024 in Review

Diligent Investors sold out of Gilead Sciences (GILD) in Q4 2024, closing a stake of 2,426 shares — an estimated $203K sold.

Diligent Investors first reported a position in GILD in Q2 2016 and held it in 20 quarters. The position peaked at $258K in Q3 2017. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

  • Diligent Investors reported no remaining Gilead Sciences position as of Q4 2024 after selling out during the quarter.
  • Diligent Investors sold 2,426 Gilead Sciences shares in Q4 2024, an estimated $203K.
  • Diligent Investors first reported a position in Gilead Sciences in Q2 2016 and held it in 20 quarters.
  • Diligent Investors's Gilead Sciences position peaked at $258K in Q3 2017.
  • 1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Diligent Investors's 13F filing for Q4 2024, filed 14 Feb 2025.